These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1574533)
21. Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety. Johnston AL; File SE Psychiatry Res; 1988 Jul; 25(1):81-90. PubMed ID: 3217470 [TBL] [Abstract][Full Text] [Related]
22. Effects of buspirone and alprazolam treatment on the startle-potentiated startle response. Commissaris RL; Fomum EA; Leavell BJ Depress Anxiety; 2004; 19(3):146-51. PubMed ID: 15129416 [TBL] [Abstract][Full Text] [Related]
23. Chronic anxiolytic treatment effects on conflict behavior in the rat. Ellis DM; Fontana DJ; McCloskey TC; Commissaris RL Pharmacol Biochem Behav; 1990 Sep; 37(1):177-86. PubMed ID: 2263660 [TBL] [Abstract][Full Text] [Related]
24. Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam. Griebel G; Blanchard DC; Jung A; Lee JC; Masuda CK; Blanchard RJ Neuropharmacology; 1995 Dec; 34(12):1625-33. PubMed ID: 8788960 [TBL] [Abstract][Full Text] [Related]
25. Possible opiate action in the anxiolytic and antinociceptive actions of alprazolam. Forman LJ; Estilow-Isabell S; Harwell M; De Salvo S; Cater J Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):259-71. PubMed ID: 2047572 [TBL] [Abstract][Full Text] [Related]
26. Alprazolam modifies animal behaviour on elevated plus-maze. Kulkarni SK; Sharma K Indian J Exp Biol; 1993 Nov; 31(11):908-11. PubMed ID: 7906673 [TBL] [Abstract][Full Text] [Related]
27. [Behavioral and electroencephalographic effects of alprazolam and its metabolites (author's transl)]. Ueki S; Watanabe S; Yamamoto T; Kataoka Y; Tazoe N; Shibata S; Shibata K; Ohta H; Kawahara K; Takano M; Suwandi D; Lee SC; Liou SY Nihon Yakurigaku Zasshi; 1981 May; 77(5):483-509. PubMed ID: 7197658 [TBL] [Abstract][Full Text] [Related]
28. Preference for alprazolam as opposed to diazepam in benzodiazepine-dependent psychiatric inpatients. Apelt S; Schmauss C; Emrich HM Pharmacopsychiatry; 1990 Mar; 23(2):70-5. PubMed ID: 1971118 [TBL] [Abstract][Full Text] [Related]
29. A controlled clinical trial of alprazolam for the treatment of anxiety. Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927 [TBL] [Abstract][Full Text] [Related]
30. Assessment of the anxiolytic and amnesic effects of three benzodiazepines, diazepam, alprazolam and triazolam, by conflict and non-matching to sample tests in mice. Kuribara H; Asahi T Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Feb; 17(1):1-6. PubMed ID: 9134532 [TBL] [Abstract][Full Text] [Related]
31. The immobility response in the forced swim test: paradoxical effect of imipramine. Abel EL; Hannigan JH Eur J Pharmacol; 1994 Jun; 258(3):261-4. PubMed ID: 8088358 [TBL] [Abstract][Full Text] [Related]
32. Imidazenil, a new anxiolytic and anticonvulsant drug, attenuates a benzodiazepine-induced cognition deficit in monkeys. Thompson DM; Auta J; Guidotti A; Costa E J Pharmacol Exp Ther; 1995 Jun; 273(3):1307-12. PubMed ID: 7791102 [TBL] [Abstract][Full Text] [Related]
33. Deletion of Dlk2 increases the vulnerability to anxiety-like behaviors and impairs the anxiolytic action of alprazolam. Navarrete F; García-Gutiérrez MS; Laborda J; Manzanares J Psychoneuroendocrinology; 2017 Nov; 85():134-141. PubMed ID: 28863347 [TBL] [Abstract][Full Text] [Related]
34. Discriminative stimulus properties of mCPP and alprazolam are not mediated by anxiety. Gommans J; Hijzen TH; Pattij T; van der Gugten J; Olivier B Pharmacol Biochem Behav; 1999 Oct; 64(2):385-7. PubMed ID: 10515318 [TBL] [Abstract][Full Text] [Related]
35. Buspirone impairs performance of a three-choice working memory water escape task in rats. Bass EW; Means LW; McMillen BA Brain Res Bull; 1992 Mar; 28(3):455-61. PubMed ID: 1591602 [TBL] [Abstract][Full Text] [Related]
36. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Wesołowska A; Nikiforuk A Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917 [TBL] [Abstract][Full Text] [Related]
37. Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defecation rate. Armario A; Gavaldà A; Martí O Eur J Pharmacol; 1988 Dec; 158(3):207-12. PubMed ID: 3253099 [TBL] [Abstract][Full Text] [Related]
38. Panic-modulating effects of alprazolam, moclobemide and sumatriptan in the rat elevated T-maze. Sant'Ana AB; Weffort LF; de Oliveira Sergio T; Gomes RC; Frias AT; Matthiesen M; Vilela-Costa HH; Yamashita PS; Vasconcelos AT; de Bortoli V; Del-Ben CM; Zangrossi H Behav Brain Res; 2016 Dec; 315():115-22. PubMed ID: 27531502 [TBL] [Abstract][Full Text] [Related]
39. Low-dose alprazolam augments motor activity in mice. Lopez F; Miller LG; Greenblatt DJ; Paul SM; Shader RI Pharmacol Biochem Behav; 1988 Jun; 30(2):511-3. PubMed ID: 2845448 [TBL] [Abstract][Full Text] [Related]